Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial Academic Article Article uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

abstract

  • Eli Lilly and Company.

publication date

  • July 30, 2016

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(16)30587-6

PubMed ID

  • 27291997

Additional Document Info

start page

  • 488

end page

  • 97

volume

  • 388

number

  • 10043